Astellas Rejigs R&D Focus Areas As It Withdraws From Mitochondria R&D

Ex-Mitobridge Asset Dropped

 
• By Lisa Takagi
  
Astellas decided to terminate its mitochondrial study and to remove the category from its primary focus.
Astellas mitochondrial R&D decision removes category as primary focus • Source: Shutterstock

More from R&D

More from Scrip